Type 1 Diabetes in Acute Pancreatitis Consortium: From Concept to Reality.
Serrano J, Laughlin MR, Bellin MD, Yadav D, Chinchilli VM, Andersen DK; Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC).
Pancreas. 2022 Jul 1;51(6):563-567. doi: 10.1097/MPA.0000000000002073.
Type 1 diabetes mellitus in patients with recurrent acute and chronic pancreatitis: A case series.
Kharoud HK, Mettler T, Freeman ML, Trikudanathan G, Beilman GJ, Chinnakotla S, Downs E, Schwarzenberg SJ, Bellin MD.
Pancreatology. 2021 Jan;21(1):95-97. doi: 10.1016/j.pan.2020.12.006. Epub 2020 Dec 6.
Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review.
Fang W, Gao Y, Shi X, Zhang X, Zhou S, Zhu H, Yan W, Wang H.
Front Immunol. 2023 Sep 28;14:1243773. doi: 10.3389/fimmu.2023.1243773. eCollection 2023.
Microbiota in pancreatic health and disease: the next frontier in microbiome research.
Thomas RM, Jobin C.
Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):53-64. doi: 10.1038/s41575-019-0242-7. Epub 2019 Dec 6.
Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.
Casu A, Grippo PJ, Wasserfall C, Sun Z, Linsley PS, Hamerman JA, Fife BT, Lacy-Hulbert A, Toledo FGS, Hart PA, Papachristou GI, Bellin MD, Yadav D, Laughlin MR, Goodarzi MO, Speake C; Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC).
Pancreas. 2022 Jul 1;51(6):580-585. doi: 10.1097/MPA.0000000000002076.
Design and Rationale for the Use of Magnetic Resonance Imaging Biomarkers to Predict Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.
Tirkes T, Chinchilli VM, Bagci U, Parker JG, Zhao X, Dasyam AK, Feranec N, Grajo JR, Shah ZK, Poullos PD, Spilseth B, Zaheer A, Xie KL, Wachsman AM, Campbell-Thompson M, Conwell DL, Fogel EL, Forsmark CE, Hart PA, Pandol SJ, Park WG, Pratley RE, Yazici C, Laughlin MR, Andersen DK, Serrano J, Bellin MD, Yadav D; Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC).
Pancreas. 2022 Jul 1;51(6):586-592. doi: 10.1097/MPA.0000000000002080.
The spectrum of diabetes in acute and chronic pancreatitis.
Olesen SS, Toledo FGS, Hart PA.
Curr Opin Gastroenterol. 2022 Sep 1;38(5):509-515. doi: 10.1097/MOG.0000000000000864. Epub 2022 Jul 18.
Recruitment and Retention Strategies for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.
Yazici C, Dyer AM, Conwell DL, Afghani E, Andersen DK, Basina M, Bellin MD, Boone LR, Casu A, Easler JJ, Greenbaum CJ, Hart PA, Jeon CY, Lee PJ, Meier S, Papachristou GI, Raja-Khan NT, Saeed ZI, Serrano J, Yadav D, Fogel EL; Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC).
Pancreas. 2022 Jul 1;51(6):598-603. doi: 10.1097/MPA.0000000000002072.
Review article: Diagnosing acute pancreatitis in diabetes mellitus.
Morton A.
Emerg Med Australas. 2022 Feb;34(1):6-8. doi: 10.1111/1742-6723.13882. Epub 2021 Oct 15.
Assessing the Pathophysiology of Hyperglycemia in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.
Dungan KM, Hart PA, Andersen DK, Basina M, Chinchilli VM, Danielson KK, Evans-Molina C, Goodarzi MO, Greenbaum CJ, Kalyani RR, Laughlin MR, Pichardo-Lowden A, Pratley RE, Serrano J, Sims EK, Speake C, Yadav D, Bellin MD, Toledo FGS; on behalf of the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC).
Pancreas. 2022 Jul 1;51(6):575-579. doi: 10.1097/MPA.0000000000002074.
